Employee engagement
Mike Crosher, Managing Director at Chugai Pharma UK shares why employee engagement, and taking time out to nurture your team during the pandemic, is...
Addressing the mental health crisis
As the nation deals with enforced isolation and increased social distancing measures to reduce the risk of spreading COVID-19, concerns have been raised about...
What does the pharma packaging and supply chain look like in 2021?
2020 was an immensely challenging year for the pharmaceutical industry. But it is also a year that will go down in history for being...
How the pandemic has changed one pharma company
Lee Gittings, Psoriasis Business Unit Director at LEO Pharma, answers Pf's questions and shares how the pandemic has changed one pharma company from the...
Streamlining biopharmaceutical data management in 2021
Graeme Dennis tells Pf why an overhaul in biopharmacuetical data management is necessary in 2021. Rarely, if ever, has the process of drug development garnered...
Increased footfall in pharmacies: Making the most of it
Involving pharmacists in the UK’s Covid-19 vaccine roll out programme not only recognises their importance, but also presents an opportunity to reignite conversations around...
The future of pharmaceutical manufacturing
When the World Health Organization (WHO) declared COVID-19 as a pandemic in March 2020, the pharmaceutical sector burst into action. By May, there were...
How pharma can enhance its digital presence
With COVID-19 accelerating online migration this year, the pharma industry has had to embrace online - and fast. Traditionally reliant on face-to-face communication and...
Reflections on regulatory information management in 2020
What has COVID-19 revealed in the way of regulatory information management (RIM) related shortcomings, and to what extent should pharmaceutical companies step up their...
Top tips for virtual medical education
Virtual solutions are one of the most effective communication channels to extend reach and frequency of engagement with customers. And following Covid-19 restrictions they...
Latest articles
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
Thousands of patients set to benefit from five-minute breast cancer treatment
An injection that cuts the amount of time breast cancer patients spend in hospital from two and a half hours to as little as...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...